Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcγ receptors

被引:118
作者
Mold, C
Baca, R
Du Clos, TW
机构
[1] VA Med Ctr, Res Serv 151, Albuquerque, NM 87108 USA
[2] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87108 USA
[3] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87108 USA
关键词
acute-phase reactants; phagocytosis; Fc receptors; autoimmunity; apoptosis;
D O I
10.1006/jaut.2002.0615
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serum amyloid P component (SAP) and C-reactive protein (CRP) are opsonins that react with nuclear autoantigens targeted in systemic autoimmunity. CRP and SAP bind to apoptotic and necrotic cells, which are potential sources of these autoantigens. We have recently determined that the receptors for CRP on phagocytic cells are Fcgamma receptors. The goal of this study was to determine whether CRP and SAP promote phagocytosis of apoptotic cells and to identify the receptors involved. Apoptosis was induced in human neutrophils (PMN) and the Jurkat T-cell line by UV-irradiation. SAP treatment of apoptotic human PMN increased ingestion by autologous macrophages. Both SAP and CRP increased ingestion of apoptotic, but not normal Jurkat cells by J-774 macrophages and mouse peritoneal macrophages. Neither SAP nor CRP increased ingestion of apoptotic Jurkat cells by macrophages from FcR gamma-chain deficient mice, which lack FcgammaRI and FcgammaRIII. Inhibition of FcgammaRIII-mediated uptake using mAb 2.4G2 eliminated opsonization by SAP, but not by CRP. These results indicate that pentraxins promote uptake of apoptotic cells through FcgammaRI and/or FcgammaRIII. Ingestion through these receptors is expected to alter the pattern of cytokine production and antigen presentation in response to apoptotic cells. Published by Elsevier Science Ltd.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 45 条
  • [11] DECREASED AUTOANTIBODY LEVELS AND ENHANCED SURVIVAL OF (NZB X NZW) F(1) MICE TREATED WITH C-REACTIVE PROTEIN
    DUCLOS, TW
    ZLOCK, LT
    HICKS, PS
    MOLD, C
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 70 (01): : 22 - 27
  • [12] DUCLOS TW, 1991, J BIOL CHEM, V266, P2167
  • [13] DUCLOS TW, 1989, J IMMUNOL, V143, P2553
  • [14] Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences
    Fadok, VA
    Bratton, DL
    Henson, PM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (07) : 957 - 962
  • [15] Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF
    Fadok, VA
    Bratton, DL
    Konowal, A
    Freed, PW
    Westcott, JY
    Henson, PM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) : 890 - 898
  • [16] Chromatin-independent binding of serum amyloid P component to apoptotic cells
    Familian, A
    Zwart, B
    Huisman, HG
    Rensink, I
    Roem, D
    Hordijk, PL
    Aarden, LA
    Hack, CE
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (02) : 647 - 654
  • [17] Phagocytosis and development: back to the future
    Franc, NC
    White, K
    Ezekowitz, RAB
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (01) : 47 - 52
  • [18] C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity
    Gershov, D
    Kim, S
    Brot, N
    Elkon, KB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (09) : 1353 - 1363
  • [19] BINDING-SPECIFICITY OF SERUM AMYLOID-P COMPONENT FOR THE PYRUVATE ACETAL OF GALACTOSE
    HIND, CRK
    COLLINS, PM
    RENN, D
    COOK, RB
    CASPI, D
    BALTZ, ML
    PEPYS, MB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (04) : 1058 - 1069
  • [20] IOANFACSINAY A, 2002, IMMUNITY, V16